Literature DB >> 8132356

Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR.

J B Kaper1, J Michalski, J M Ketley, M M Levine.   

Abstract

The potential for reacquisition of ctxA genes by attenuated Vibrio cholerae O1 vaccine strain CVD 103-HgR was examined by performing a series of mating experiments under a variety of in vivo and in vitro conditions. We found no evidence that CVD 103-HgR could reacquire ctxA genes from wild-type V. cholerae O1 strains. However, if the donor V. cholerae O1 strains were genetically manipulated to add genes that allow chromosomal gene transfer, then ctxA sequences could be acquired by CVD 103-HgR. The minimal excretion of CVD 103-HgR by vaccinees and the refractoriness to reacquisition of ctxA sequences suggest that this well-tolerated, highly immunogenic live oral cholera vaccine will have a minimal environmental impact.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132356      PMCID: PMC186308          DOI: 10.1128/iai.62.4.1480-1483.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.

Authors:  C Simanjuntak; N Witham; N Punjabi; D G Heppner; G Losonsky; H Totosudirjo; A R Rifai; J Clemens; Y L Lim
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

2.  Observations of the nature of genetic recombination in Vibrio cholerae.

Authors:  K BHASKARAN
Journal:  Indian J Med Res       Date:  1959-05       Impact factor: 2.375

3.  Genetic recombination in Vibrio cholerae.

Authors:  K BHASKARAN
Journal:  J Gen Microbiol       Date:  1958-08

4.  Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.

Authors:  R A Cash; S I Music; J P Libonati; M J Snyder; R P Wenzel; R B Hornick
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

Review 5.  Live oral vaccines against cholera: an update.

Authors:  M M Levine; J B Kaper
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

6.  CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.

Authors:  J Michalski; J E Galen; A Fasano; J B Kaper
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.

Authors:  C H Simanjuntak; P O'Hanley; N H Punjabi; F Noriega; G Pazzaglia; P Dykstra; B Kay; A Budiarso; A R Rifai
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

8.  Construction of genetically marked Vibrio cholerae O1 vaccine strains.

Authors:  J M Ketley; J Michalski; J Galen; M M Levine; J B Kaper
Journal:  FEMS Microbiol Lett       Date:  1993-07-15       Impact factor: 2.742

9.  Isolation and characterization of the fertility factor P of Vibrio cholerae.

Authors:  A Datta; C D Parker; J A Wohlhieter; L S Baron
Journal:  J Bacteriol       Date:  1973-02       Impact factor: 3.490

10.  Self-transfer and genetic recombination mediated by P, the sex factor of Vibrio cholerae.

Authors:  C Parker; W R Romig
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

View more
  7 in total

1.  Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.

Authors:  D N Taylor; C O Tacket; G Losonsky; O Castro; J Gutierrez; R Meza; J P Nataro; J B Kaper; S S Wasserman; R Edelman; M M Levine; S J Cryz
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

2.  Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain.

Authors:  E T Ryan; J R Butterton; R N Smith; P A Carroll; T I Crean; S B Calderwood
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.

Authors:  E T Ryan; J R Butterton; T Zhang; M A Baker; S L Stanley; S B Calderwood
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae.

Authors:  D K Karaolis; R Lan; P R Reeves
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

5.  Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.

Authors:  Tew Hui Xian; Kurunathan Sinniah; Chan Yean Yean; Venkateskumar Krishnamoorthy; Mohd Baidi Bahari; Manickam Ravichandran; Guruswamy Prabhakaran
Journal:  BMC Immunol       Date:  2020-05-25       Impact factor: 3.615

6.  Fishing for vaccines against Vibrio cholerae using in silico pan-proteomic reverse vaccinology approach.

Authors:  Muhammad I Rashid; Sammia Rehman; Amjad Ali; Saadia Andleeb
Journal:  PeerJ       Date:  2019-06-19       Impact factor: 2.984

Review 7.  Acute, infectious diarrhea among children in developing countries.

Authors:  Laura Jean Podewils; Eric D Mintz; James P Nataro; Umesh D Parashar
Journal:  Semin Pediatr Infect Dis       Date:  2004-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.